Cargando…

(18)F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival

Objectives: (1.1) to evaluate the association between baseline 18F-FDG PET/CT semi-quantitative parameters of the primary lesion with progression free survival (PFS), overall survival (OS) and response to immunotherapy, in advanced non-small cell lung carcinoma (NSCLC) patients eligible for immunoth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polverari, Giulia, Ceci, Francesco, Bertaglia, Valentina, Reale, Maria Lucia, Rampado, Osvaldo, Gallio, Elena, Passera, Roberto, Liberini, Virginia, Scapoli, Paola, Arena, Vincenzo, Racca, Manuela, Veltri, Andrea, Novello, Silvia, Deandreis, Désirée
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281558/ https://www.ncbi.nlm.nih.gov/pubmed/32380754 http://dx.doi.org/10.3390/cancers12051163

Ejemplares similares

Impact of segmentation and discretization on radiomic features in (68)Ga-DOTA-TOC PET/CT images of neuroendocrine tumor
por: Liberini, Virginia, et al.
Publicado: (2021)

Diagnostic Value of Conventional PET Parameters and Radiomic Features Extracted from 18F-FDG-PET/CT for Histologic Subtype Classification and Characterization of Lung Neuroendocrine Neoplasms
por: Thuillier, Philippe, et al.
Publicado: (2021)

(68)Ga-DOTATOC PET/CT-Based Radiomic Analysis and PRRT Outcome: A Preliminary Evaluation Based on an Exploratory Radiomic Analysis on Two Patients
por: Liberini, Virginia, et al.
Publicado: (2021)

Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma
por: Liberini, Virginia, et al.
Publicado: (2021)

Applications of Artificial Intelligence and Radiomics in Molecular Hybrid Imaging and Theragnostics for Neuro-Endocrine Neoplasms (NENs)
por: Balma, Michele, et al.
Publicado: (2023)

NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images
por: Liberini, Virginia, et al.
Publicado: (2021)

COVID-19 and Aspiration Pneumonia: Similar Pulmonary Findings with Different Diagnoses—a Pitfall in [18F]FDG PET/CT
por: Liberini, Virginia, et al.
Publicado: (2021)

Event-free survival after (68) Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy
por: Ceci, Francesco, et al.
Publicado: (2022)

BSREM for Brain Metastasis Detection with 18F-FDG-PET/CT in Lung Cancer Patients
por: Liberini, Virginia, et al.
Publicado: (2022)

Improved detection of in-transit metastases of malignant melanoma with BSREM reconstruction in digital [(18)F]FDG PET/CT
por: Liberini, Virginia, et al.
Publicado: (2021)

[(18)F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial
por: Polverari, Giulia, et al.
Publicado: (2020)

The Future of Cancer Diagnosis, Treatment and Surveillance: A Systemic Review on Immunotherapy and Immuno-PET Radiotracers
por: Liberini, Virginia, et al.
Publicado: (2021)

[(68)Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [(177)Lu]DOTATOC PRRT: The “Theragnomics” Concept
por: Laudicella, Riccardo, et al.
Publicado: (2022)

(18)F-Fluorodeoxyglucose Uptake in Patient With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Referred to Positron Emission Tomography/Computed Tomography for NSCLC Restaging
por: Polverari, Giulia, et al.
Publicado: (2020)

Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics
por: Liberini, Virginia, et al.
Publicado: (2022)

Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review
por: Balma, Michele, et al.
Publicado: (2022)

Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics
por: van Timmeren, Janna E., et al.
Publicado: (2019)

Machine Learning CT-Based Automatic Nodal Segmentation and PET Semi-Quantification of Intraoperative (68)Ga-PSMA-11 PET/CT Images in High-Risk Prostate Cancer: A Pilot Study
por: Rovera, Guido, et al.
Publicado: (2023)

Predictive Power of a Radiomic Signature Based on (18)F-FDG PET/CT Images for EGFR Mutational Status in NSCLC
por: Li, Xiaofeng, et al.
Publicado: (2019)

Hematogenous muscular metastasis of NSCLC in FDG-PET/CT
por: Satoh, Hiroaki, et al.
Publicado: (2015)

A GPU Simulation Tool for Training and Optimisation in 2D Digital X-Ray Imaging
por: Gallio, Elena, et al.
Publicado: (2015)

Improved diagnosis of pelvic lesions with dual-phase (18F)FDG-PET/CT
por: Pelosi, Ettore, et al.
Publicado: (2015)

Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL
por: Mazzara, Saveria, et al.
Publicado: (2022)

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?
por: Passiglia, Francesco, et al.
Publicado: (2021)

PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology
por: Sollini, M., et al.
Publicado: (2017)

Management of Oligoprogression in Patients with Metastatic NSCLC Harboring ALK Rearrangements
por: Pisano, Chiara, et al.
Publicado: (2022)

PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature
por: Evangelista, Laura, et al.
Publicado: (2023)

Prognostic value of FDG-PET radiomics with machine learning in pancreatic cancer
por: Toyama, Yoshitaka, et al.
Publicado: (2020)

The Impact of Artificial Intelligence CNN Based Denoising on FDG PET Radiomics
por: Jaudet, Cyril, et al.
Publicado: (2021)

Artificial intelligence for reduced dose 18F-FDG PET examinations: a real-world deployment through a standardized framework and business case assessment
por: Katsari, Katia, et al.
Publicado: (2021)

Non-invasive decision support for NSCLC treatment using PET/CT radiomics
por: Mu, Wei, et al.
Publicado: (2020)

Early and Complete Response of Bone Metastases, Documented by FDG-PET/CT Scan, in a Patient With NSCLC
por: Rossi, David, et al.
Publicado: (2012)

FDG and Non-FDG Radiopharmaceuticals for PET Imaging in Invasive Lobular Breast Carcinoma
por: Gilardi, Laura, et al.
Publicado: (2023)

Predictors of Bone Metastases at (68)Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or Persistence
por: Rovera, Guido, et al.
Publicado: (2022)

False negative rate at (18)F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technology
por: Gouy, Sebastien, et al.
Publicado: (2021)

Assessing the role of colonic and other anatomical sites uptake by [(18)F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors
por: Rizzo, Alessio, et al.
Publicado: (2023)

Assessing radiomic feature robustness to interpolation in (18)F-FDG PET imaging
por: Whybra, Philip, et al.
Publicado: (2019)

Radiomics and supervised machine learning in the diagnosis of parkinsonism with FDG PET: promises and challenges
por: Peng, Shichun, et al.
Publicado: (2020)

Radiomic Features of (18)F-FDG PET in Hodgkin Lymphoma Are Predictive of Outcomes
por: Zhou, Yeye, et al.
Publicado: (2021)

The Influence of the Exclusion of Central Necrosis on [(18)F]FDG PET Radiomic Analysis
por: Noortman, Wyanne A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l9ldqep1gcc607m5t7nbuak111